Covalent Data

Denver, United States Founded: 2011 • Age: 15 yrs Acquired By Wellspring
Licensing opportunities for technologies are identified through innovation intelligence platforms.

About Covalent Data

Covalent Data is a Healthcare company based in Denver (United States) founded in 2011, and was acquired by Wellspring in July 2017. Licensing opportunities for technologies are identified through innovation intelligence platforms. Covalent Data has raised $4.75 million across 3 funding rounds from investors including Wellspring and High Country Ventures. Covalent Data offers products and services including Accolade, Scout, Evolve, and Astria. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include ProQuest, Authorea and Research Solutions; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2011 and based in Denver, United States, Covalent Data operates in the technology sector as a platform for licensing and innovation intelligence. Public and private data sets are integrated to map the global innovation landscape, enabling the tracking of inventions from initial research to commercialization. Trends are analyzed, opportunities are evaluated, and connections among ecosystem participants are facilitated.

Key Metrics
  • Total Equity Funding
    $4.75M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.2M (USD), Series A

    Apr 2016

  • Investors
    Wellspring

    & 1 more

  • Acquired by
    Wellspring

    (Jul 2017)

Products & Services of Covalent Data

Covalent Data offers a comprehensive portfolio of products and services, including Accolade, Scout, Evolve, and Astria.

Accolade
Innovation Management

Tool for managing innovation processes and strategies

Scout
Tech Scouting

Platform for searching and identifying technologies

Evolve
Innovation Management

Software for evolving innovation strategies

Astria
IP Management

System for handling intellectual property tasks

Funding Insights of Covalent Data

Covalent Data has successfully raised a total of $4.75M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1.2 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.75M
  • Total Rounds 3
  • Last Round Series A β€” $1.2M
  • First Round $1.05M

    (Jun 2012)

  • Investors Count 1

All 3 funding rounds of Covalent Data with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2016$1.2MSeries A–High Country Ventures
–
Nov 2013$2.5MSeries A–High Country Ventures
–
Jun 2012$1.05MSeed––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Covalent Data

Covalent Data has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Wellspring and High Country Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage centric life sciences and tech focused VC firm investing primarily in the US
highcountryventure.comBoulder, United States
AI platform for technology scouting and corporate venturing is offered.
2003wellspring.comChicago, United States
Premium access

Investor details for Covalent Data

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Covalent Data

4 dated milestones of Covalent Data across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Covalent Data is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Series A, of $1.2M.
  4. Exit Acquired by Wellspring.

Competitors of Covalent Data

Covalent Data has 3 listed competitors in our database, 2 of them funded. They include ProQuest, Authorea and Research Solutions.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
proquest.com2008Ann Arbor, United States
Research content is delivered via online platforms to libraries.
authorea.com2012New York, United States$2.11M88
Collaborative platform for research and learning
researchsolutions.com2006Henderson, United States$12.06M34
AI-powered solutions for scholarly content access and management are provided.
Premium access

Detailed competitors of Covalent Data

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Covalent Data (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Covalent Data

Premium access

Complete news archive for Covalent Data

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Covalent Data

Covalent Data was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Covalent Data is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Covalent Data is a funded company, having raised a total of $4.75M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.05M, raised on Jun 2012.

Founded in 2011 and based in Denver, United States, Covalent Data operates in the technology sector as a platform for licensing and innovation intelligence. Public and private data sets are integrated to map the global innovation landscape, enabling the tracking of inventions from initial research to commercialization. Trends are analyzed, opportunities are evaluated, and connections among ecosystem participants are facilitated.

Covalent Data's top competitors include ProQuest, Research Solutions and Authorea.

Covalent Data offers Accolade, Scout, Evolve, and Astria.

Covalent Data has 2 investors. Key investors include Wellspring, and High Country Ventures.

Yes. Covalent Data was acquired by Wellspring in July 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available